In partnership with the Symposium on Advanced Wound Care (SAWC), AIROS is proud to support, sponsor, and co-present a Virtual Wound Rounds session on May 27 entitled, “LOVE: Lymphedema. Origin. Venous. Etiology.). Registration is free – learn more today!
We are proud to announce our 2021 Premier Sponsorship of the Lymphology Association of North America® (LANA)! LANA is a non-profit corporation specializing in the certification of healthcare professionals who diagnose and/or treat lymphedema and related disorders.
March is Lymphedema Awareness Month, during which the clinical, patient, and advocacy communities, as well as the private sector, join forces to increase awareness of this chronic condition. We are proud to be partnering with various organizations to do our part in spreading the word.
We had a successful showing at The Southern Association for Vascular Surgery’s (SAVS) 45th Annual Meeting in Scottsdale at the end of last month. This hybrid event included a virtual and live event, and was the first in-person conference we’ve attended since March of last year.
Despite all the challenges of moving the 2020 National Lymphedema Network (NLN) Conference online, the virtual event was an impressive industry success, and we were thrilled with the results!
Gerry Makoid, our president & CEO, appeared for interviews on Comcast’s “Money Matters” and RVNTV’s “The Advocates.” Topics discussed include the history of our company, business and manufacturing, and the healthcare conditions our products treat daily.
The Lymphatic Education & Research Network’s (LE&RN) newly-recognized Centers of Excellence, including a facility at the Children’s Hospital of Philadelphia (CHOP), have been recognized as leaders paving the way for the diagnosis and treatment of lymphatic disease.
AIROS® Medical, Inc., a medical technology manufacturer specializing in compression therapy products that treat cancer-related lymphedema and venous complications, today announced the launch of its updated AIROS 6 Sequential Compression Therapy device and Arm Plus garments following multiple regulatory approvals.